Home > > > > Report Detail

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Research Report 2023

Publisher Name :
Date: 07-Jan-2023
No. of pages: 100
Inquire Before Buying

A biomarker is, according to the US National Institutes of Health, "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention."

Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.

Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.

We can discriminate four main types of molecular biomarkers:

• Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.

• Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.

• Proteomic biomarkers: Base on the analysis of the protein profiles.

• Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).

Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.

Highlights

The global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market was valued at US$ 22500 million in 2022 and is anticipated to reach US$ 29810 million by 2029, witnessing a CAGR of 4.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market include Roche, Dako (Agilent Technologies), Affymetrix, etc. The top 3 players occupy about 10% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Consumables is the main type, with a share about 60%. The main applications include Oncology, Cardiology, Neurology, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Commercializing Biomarkers in Therapeutic and Diagnostic Applications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Commercializing Biomarkers in Therapeutic and Diagnostic Applications.

The Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Commercializing Biomarkers in Therapeutic and Diagnostic Applications companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Roche

- Dako (Agilent Technologies)

- Merck

- BD

- Abbott

- Genesys Biolabs (20/20GeneSystems)

- Affymetrix

- Agendia

- ALMAC

- Arrayit

- Biocartic

- BG Medicine

- KEGG EXPRESSION Database

- Thermo Fisher

- BGI

Segment by Type

- Consumables

- Services

- Software

Segment by Application

- Oncology

- Cardiology

- Neurology

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Research Report 2023

Table of Contents
1 Differential Scanning Calorimeter (DSC) Market Overview
1.1 Product Definition
1.2 Differential Scanning Calorimeter (DSC) Segment by Type
1.2.1 Global Differential Scanning Calorimeter (DSC) Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Heat Flux DSC
1.2.3 Power-compensation DSC
1.3 Differential Scanning Calorimeter (DSC) Segment by Application
1.3.1 Global Differential Scanning Calorimeter (DSC) Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Drug Analysis
1.3.3 General Chemical Analysis
1.3.4 Food Science
1.3.5 Polymers
1.3.6 Metals
1.4 Global Market Growth Prospects
1.4.1 Global Differential Scanning Calorimeter (DSC) Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Differential Scanning Calorimeter (DSC) Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Differential Scanning Calorimeter (DSC) Production Estimates and Forecasts (2018-2029)
1.4.4 Global Differential Scanning Calorimeter (DSC) Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Differential Scanning Calorimeter (DSC) Production Market Share by Manufacturers (2018-2023)
2.2 Global Differential Scanning Calorimeter (DSC) Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Differential Scanning Calorimeter (DSC), Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Differential Scanning Calorimeter (DSC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Differential Scanning Calorimeter (DSC) Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Differential Scanning Calorimeter (DSC), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Differential Scanning Calorimeter (DSC), Product Offered and Application
2.8 Global Key Manufacturers of Differential Scanning Calorimeter (DSC), Date of Enter into This Industry
2.9 Differential Scanning Calorimeter (DSC) Market Competitive Situation and Trends
2.9.1 Differential Scanning Calorimeter (DSC) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Differential Scanning Calorimeter (DSC) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Differential Scanning Calorimeter (DSC) Production by Region
3.1 Global Differential Scanning Calorimeter (DSC) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Differential Scanning Calorimeter (DSC) Production Value by Region (2018-2029)
3.2.1 Global Differential Scanning Calorimeter (DSC) Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Differential Scanning Calorimeter (DSC) by Region (2024-2029)
3.3 Global Differential Scanning Calorimeter (DSC) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Differential Scanning Calorimeter (DSC) Production by Region (2018-2029)
3.4.1 Global Differential Scanning Calorimeter (DSC) Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Differential Scanning Calorimeter (DSC) by Region (2024-2029)
3.5 Global Differential Scanning Calorimeter (DSC) Market Price Analysis by Region (2018-2023)
3.6 Global Differential Scanning Calorimeter (DSC) Production and Value, Year-over-Year Growth
3.6.1 North America Differential Scanning Calorimeter (DSC) Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Differential Scanning Calorimeter (DSC) Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Differential Scanning Calorimeter (DSC) Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Differential Scanning Calorimeter (DSC) Production Value Estimates and Forecasts (2018-2029)
4 Differential Scanning Calorimeter (DSC) Consumption by Region
4.1 Global Differential Scanning Calorimeter (DSC) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Differential Scanning Calorimeter (DSC) Consumption by Region (2018-2029)
4.2.1 Global Differential Scanning Calorimeter (DSC) Consumption by Region (2018-2023)
4.2.2 Global Differential Scanning Calorimeter (DSC) Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Differential Scanning Calorimeter (DSC) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Differential Scanning Calorimeter (DSC) Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Differential Scanning Calorimeter (DSC) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Differential Scanning Calorimeter (DSC) Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Differential Scanning Calorimeter (DSC) Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Differential Scanning Calorimeter (DSC) Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Differential Scanning Calorimeter (DSC) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Differential Scanning Calorimeter (DSC) Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Differential Scanning Calorimeter (DSC) Production by Type (2018-2029)
5.1.1 Global Differential Scanning Calorimeter (DSC) Production by Type (2018-2023)
5.1.2 Global Differential Scanning Calorimeter (DSC) Production by Type (2024-2029)
5.1.3 Global Differential Scanning Calorimeter (DSC) Production Market Share by Type (2018-2029)
5.2 Global Differential Scanning Calorimeter (DSC) Production Value by Type (2018-2029)
5.2.1 Global Differential Scanning Calorimeter (DSC) Production Value by Type (2018-2023)
5.2.2 Global Differential Scanning Calorimeter (DSC) Production Value by Type (2024-2029)
5.2.3 Global Differential Scanning Calorimeter (DSC) Production Value Market Share by Type (2018-2029)
5.3 Global Differential Scanning Calorimeter (DSC) Price by Type (2018-2029)
6 Segment by Application
6.1 Global Differential Scanning Calorimeter (DSC) Production by Application (2018-2029)
6.1.1 Global Differential Scanning Calorimeter (DSC) Production by Application (2018-2023)
6.1.2 Global Differential Scanning Calorimeter (DSC) Production by Application (2024-2029)
6.1.3 Global Differential Scanning Calorimeter (DSC) Production Market Share by Application (2018-2029)
6.2 Global Differential Scanning Calorimeter (DSC) Production Value by Application (2018-2029)
6.2.1 Global Differential Scanning Calorimeter (DSC) Production Value by Application (2018-2023)
6.2.2 Global Differential Scanning Calorimeter (DSC) Production Value by Application (2024-2029)
6.2.3 Global Differential Scanning Calorimeter (DSC) Production Value Market Share by Application (2018-2029)
6.3 Global Differential Scanning Calorimeter (DSC) Price by Application (2018-2029)
7 Key Companies Profiled
7.1 TA Instruments
7.1.1 TA Instruments Differential Scanning Calorimeter (DSC) Corporation Information
7.1.2 TA Instruments Differential Scanning Calorimeter (DSC) Product Portfolio
7.1.3 TA Instruments Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.1.4 TA Instruments Main Business and Markets Served
7.1.5 TA Instruments Recent Developments/Updates
7.2 NETZSCH
7.2.1 NETZSCH Differential Scanning Calorimeter (DSC) Corporation Information
7.2.2 NETZSCH Differential Scanning Calorimeter (DSC) Product Portfolio
7.2.3 NETZSCH Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.2.4 NETZSCH Main Business and Markets Served
7.2.5 NETZSCH Recent Developments/Updates
7.3 Mettler-Toledo
7.3.1 Mettler-Toledo Differential Scanning Calorimeter (DSC) Corporation Information
7.3.2 Mettler-Toledo Differential Scanning Calorimeter (DSC) Product Portfolio
7.3.3 Mettler-Toledo Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Mettler-Toledo Main Business and Markets Served
7.3.5 Mettler-Toledo Recent Developments/Updates
7.4 PerkinElmer
7.4.1 PerkinElmer Differential Scanning Calorimeter (DSC) Corporation Information
7.4.2 PerkinElmer Differential Scanning Calorimeter (DSC) Product Portfolio
7.4.3 PerkinElmer Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.4.4 PerkinElmer Main Business and Markets Served
7.4.5 PerkinElmer Recent Developments/Updates
7.5 Malvern
7.5.1 Malvern Differential Scanning Calorimeter (DSC) Corporation Information
7.5.2 Malvern Differential Scanning Calorimeter (DSC) Product Portfolio
7.5.3 Malvern Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Malvern Main Business and Markets Served
7.5.5 Malvern Recent Developments/Updates
7.6 Shimadzu
7.6.1 Shimadzu Differential Scanning Calorimeter (DSC) Corporation Information
7.6.2 Shimadzu Differential Scanning Calorimeter (DSC) Product Portfolio
7.6.3 Shimadzu Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Shimadzu Main Business and Markets Served
7.6.5 Shimadzu Recent Developments/Updates
7.7 Setaram
7.7.1 Setaram Differential Scanning Calorimeter (DSC) Corporation Information
7.7.2 Setaram Differential Scanning Calorimeter (DSC) Product Portfolio
7.7.3 Setaram Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Setaram Main Business and Markets Served
7.7.5 Setaram Recent Developments/Updates
7.8 Hitachi
7.8.1 Hitachi Differential Scanning Calorimeter (DSC) Corporation Information
7.8.2 Hitachi Differential Scanning Calorimeter (DSC) Product Portfolio
7.8.3 Hitachi Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Hitachi Main Business and Markets Served
7.7.5 Hitachi Recent Developments/Updates
7.9 Rigaku
7.9.1 Rigaku Differential Scanning Calorimeter (DSC) Corporation Information
7.9.2 Rigaku Differential Scanning Calorimeter (DSC) Product Portfolio
7.9.3 Rigaku Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Rigaku Main Business and Markets Served
7.9.5 Rigaku Recent Developments/Updates
7.10 Linseis
7.10.1 Linseis Differential Scanning Calorimeter (DSC) Corporation Information
7.10.2 Linseis Differential Scanning Calorimeter (DSC) Product Portfolio
7.10.3 Linseis Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Linseis Main Business and Markets Served
7.10.5 Linseis Recent Developments/Updates
7.11 Beijing Henven
7.11.1 Beijing Henven Differential Scanning Calorimeter (DSC) Corporation Information
7.11.2 Beijing Henven Differential Scanning Calorimeter (DSC) Product Portfolio
7.11.3 Beijing Henven Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Beijing Henven Main Business and Markets Served
7.11.5 Beijing Henven Recent Developments/Updates
7.12 Nanjing Dazhan
7.12.1 Nanjing Dazhan Differential Scanning Calorimeter (DSC) Corporation Information
7.12.2 Nanjing Dazhan Differential Scanning Calorimeter (DSC) Product Portfolio
7.12.3 Nanjing Dazhan Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Nanjing Dazhan Main Business and Markets Served
7.12.5 Nanjing Dazhan Recent Developments/Updates
7.13 Shanghai Innuo
7.13.1 Shanghai Innuo Differential Scanning Calorimeter (DSC) Corporation Information
7.13.2 Shanghai Innuo Differential Scanning Calorimeter (DSC) Product Portfolio
7.13.3 Shanghai Innuo Differential Scanning Calorimeter (DSC) Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Shanghai Innuo Main Business and Markets Served
7.13.5 Shanghai Innuo Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Differential Scanning Calorimeter (DSC) Industry Chain Analysis
8.2 Differential Scanning Calorimeter (DSC) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Differential Scanning Calorimeter (DSC) Production Mode & Process
8.4 Differential Scanning Calorimeter (DSC) Sales and Marketing
8.4.1 Differential Scanning Calorimeter (DSC) Sales Channels
8.4.2 Differential Scanning Calorimeter (DSC) Distributors
8.5 Differential Scanning Calorimeter (DSC) Customers
9 Differential Scanning Calorimeter (DSC) Market Dynamics
9.1 Differential Scanning Calorimeter (DSC) Industry Trends
9.2 Differential Scanning Calorimeter (DSC) Market Drivers
9.3 Differential Scanning Calorimeter (DSC) Market Challenges
9.4 Differential Scanning Calorimeter (DSC) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Consumables
Table 3. Key Players of Services
Table 4. Key Players of Software
Table 5. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Region (2018-2023)
Table 9. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Region (2024-2029)
Table 11. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Trends
Table 12. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Drivers
Table 13. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Challenges
Table 14. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Restraints
Table 15. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Players (2018-2023)
Table 17. Global Top Commercializing Biomarkers in Therapeutic and Diagnostic Applications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications as of 2022)
Table 18. Ranking of Global Top Commercializing Biomarkers in Therapeutic and Diagnostic Applications Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Solution and Service
Table 22. Date of Enter into Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Type (2018-2023)
Table 26. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Type (2024-2029)
Table 28. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Application (2018-2023)
Table 30. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Application (2024-2029)
Table 32. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size by Country (2024-2029) & (US$ Million)
Table 47. Roche Company Detail
Table 48. Roche Business Overview
Table 49. Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 50. Roche Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Dako (Agilent Technologies) Company Detail
Table 53. Dako (Agilent Technologies) Business Overview
Table 54. Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 55. Dako (Agilent Technologies) Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 56. Dako (Agilent Technologies) Recent Development
Table 57. Merck Company Detail
Table 58. Merck Business Overview
Table 59. Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 60. Merck Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 61. Merck Recent Development
Table 62. BD Company Detail
Table 63. BD Business Overview
Table 64. BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 65. BD Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 66. BD Recent Development
Table 67. Abbott Company Detail
Table 68. Abbott Business Overview
Table 69. Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 70. Abbott Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Genesys Biolabs (20/20GeneSystems) Company Detail
Table 73. Genesys Biolabs (20/20GeneSystems) Business Overview
Table 74. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 75. Genesys Biolabs (20/20GeneSystems) Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 76. Genesys Biolabs (20/20GeneSystems) Recent Development
Table 77. Affymetrix Company Detail
Table 78. Affymetrix Business Overview
Table 79. Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 80. Affymetrix Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 81. Affymetrix Recent Development
Table 82. Agendia Company Detail
Table 83. Agendia Business Overview
Table 84. Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 85. Agendia Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 86. Agendia Recent Development
Table 87. ALMAC Company Detail
Table 88. ALMAC Business Overview
Table 89. ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 90. ALMAC Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 91. ALMAC Recent Development
Table 92. Arrayit Company Detail
Table 93. Arrayit Business Overview
Table 94. Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 95. Arrayit Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 96. Arrayit Recent Development
Table 97. Biocartic Company Detail
Table 98. Biocartic Business Overview
Table 99. Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 100. Biocartic Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 101. Biocartic Recent Development
Table 102. BG Medicine Company Detail
Table 103. BG Medicine Business Overview
Table 104. BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 105. BG Medicine Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 106. BG Medicine Recent Development
Table 107. KEGG EXPRESSION Database Company Detail
Table 108. KEGG EXPRESSION Database Business Overview
Table 109. KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 110. KEGG EXPRESSION Database Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 111. KEGG EXPRESSION Database Recent Development
Table 112. Thermo Fisher Company Detail
Table 113. Thermo Fisher Business Overview
Table 114. Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 115. Thermo Fisher Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 116. Thermo Fisher Recent Development
Table 117. BGI Company Detail
Table 118. BGI Business Overview
Table 119. BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product
Table 120. BGI Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications Business (2018-2023) & (US$ Million)
Table 121. BGI Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Type: 2022 VS 2029
Figure 3. Consumables Features
Figure 4. Services Features
Figure 5. Software Features
Figure 6. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Application: 2022 VS 2029
Figure 8. Oncology Case Studies
Figure 9. Cardiology Case Studies
Figure 10. Neurology Case Studies
Figure 11. Other Case Studies
Figure 12. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report Years Considered
Figure 13. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Region: 2022 VS 2029
Figure 16. Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Players in 2022
Figure 17. Global Top Commercializing Biomarkers in Therapeutic and Diagnostic Applications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercializing Biomarkers in Therapeutic and Diagnostic Applications as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue in 2022
Figure 19. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Country (2018-2029)
Figure 21. United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Country (2018-2029)
Figure 25. Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Region (2018-2029)
Figure 33. China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Country (2018-2029)
Figure 41. Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share by Country (2018-2029)
Figure 45. Turkey Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Commercializing
  • Global Biomarkers Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period. The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
  • Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Biomarker (Medicine) market: According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years. Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
  • Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Commercializing Biom......
  • Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Biomarkers market: According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
  • Global Biomarker Technology Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Quanterix - Bio-Rad Laboratories - Epigenomics - Agilent Technologies - Johnson & Johnson - Qiagen - Roche Ho......
  • Global Renal Biomarkers Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 99
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Diagnostics - F. Hoffmann-La Roche - Beckman Coulter - Siemens Healthcare Diagnostics - Thermo Fisher Scientific - Astute Medical - Bio......
  • Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Central Nervous System (CNS) Biomarkers market: According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. An overview of the global market for central nervous system (CNS) biomarke......
  • Global Cancer Biomarker Market Research Report 2023
    Published: 13-Nov-2023        Price: US 2900 Onwards        Pages: 109
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Bio-Rad Laboratories - Roche Diagnostics - Qiagen - Illumina - GE Healthcare - Agilent Technologies - Biomér......
  • Biomarker Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs